These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

159 related items for PubMed ID: 7539572

  • 1. [Is it possible to do without bone gammagraphy in the staging of prostatic cancer?].
    Ruiz de la Roja JC, Llorente Abarca C, Romero Cagigal I, Páez Borda A, Fernández González I, Martín Osés E, Berenguer Sánchez A.
    Actas Urol Esp; 1995 Feb; 19(2):123-7. PubMed ID: 7539572
    [Abstract] [Full Text] [Related]

  • 2. Bone scan in initial staging of prostate cancer.
    Boughattas S, Letaief B, Hassine H, Chatti K, Essabah H.
    Tunis Med; 2003 Jun; 81(6):400-6. PubMed ID: 14534946
    [Abstract] [Full Text] [Related]

  • 3. Prostate-specific antigen, Gleason sum and clinical T stage for predicting the need for radionuclide bone scan for prostate cancer patients in Japan.
    Ishizuka O, Tanabe T, Nakayama T, Kawakami M, Kinebuchi Y, Nishizawa O.
    Int J Urol; 2005 Aug; 12(8):728-32. PubMed ID: 16174046
    [Abstract] [Full Text] [Related]

  • 4. [Can we do without bone gammagraphy in the staging of prostatic cancer?].
    Morote J, Olona M, Villa J, Reig C, López MA, de Torres JA, Soler A.
    Actas Urol Esp; 1992 Jun; 16(6):487-9; discussion 489-90. PubMed ID: 1509919
    [Abstract] [Full Text] [Related]

  • 5. [Correlation of prostatic specific antigen, tumor grade, and local stage with bone scintigraphy in the staging of patients with prostatic cancer].
    Herranz Amo F, Díez Cordero JM, Verdú Tartajo F, Lledó García E, Subirá Castillón C, González Chamorro F, Rodríguez Fernández E.
    Arch Esp Urol; 1997 Apr; 50(3):253-8. PubMed ID: 9144973
    [Abstract] [Full Text] [Related]

  • 6. [Predictive value of prostate-specific antigen and Gleason sum for results of radionuclide bone scintigraphy in patients with prostate cancer].
    Wang TY, Chen XP, Li XS, Jia Yx, Cheng J, Zhang JH, Cai L, Zhang Z, Gong K, He ZS, Zhou LQ.
    Beijing Da Xue Xue Bao Yi Xue Ban; 2012 Aug 18; 44(4):528-34. PubMed ID: 22898839
    [Abstract] [Full Text] [Related]

  • 7. Prostate-specific antigen as a marker of bone metastasis in patients with prostate cancer.
    Wolff JM, Bares R, Jung PK, Buell U, Jakse G.
    Urol Int; 1996 Aug 18; 56(3):169-73. PubMed ID: 8860738
    [Abstract] [Full Text] [Related]

  • 8. [Relationship between pretreatment serum levels of prostate specific antigen and bone metastasis in prostate cancer].
    Kageyama Y, Kihara K, Kamata S, Nagahama K, Yonese J, Fukuda H, Tosaka A, Nagamatsu H, Ishizaka K, Tsujii T, Kitahara S, Morita T, Oshima H.
    Hinyokika Kiyo; 1996 Mar 18; 42(3):197-9. PubMed ID: 8619388
    [Abstract] [Full Text] [Related]

  • 9. [Correlation between specific prostatic antigen and findings with total body bone scintigraphy].
    López M, Montes De Oca L, Bernardo N, Scorticati C, Suárez P, Bencardino F, De Lasa T, Sotero Falco E, Coimbra F, Scorticati C.
    Arch Esp Urol; 1996 Nov 18; 49(9):953-5. PubMed ID: 9133295
    [Abstract] [Full Text] [Related]

  • 10. The value of serum prostate specific antigen and other parameters in detecting bone metastases in prostate cancer.
    Ataus S, Citçi A, Alici B, Onder AU, Sönmezoğlu K, Erözenci A, Solok V.
    Int Urol Nephrol; 1999 Nov 18; 31(4):481-9. PubMed ID: 10668943
    [Abstract] [Full Text] [Related]

  • 11. [When should we perform a bone scintigraphy in patients with new diagnosis of asymptomatic prostate cancer in order to detect bone metastasis?].
    Márquez-López J, Gómez-Gómez E, Anaya-Henares F, Robles-Casilda R, Requena-Tapia MJ.
    Arch Esp Urol; 2015 Mar 18; 68(2):135-41. PubMed ID: 25774820
    [Abstract] [Full Text] [Related]

  • 12. Serum bone alkaline phosphatase levels enhance the clinical utility of prostate specific antigen in the staging of newly diagnosed prostate cancer patients.
    Lorente JA, Valenzuela H, Morote J, Gelabert A.
    Eur J Nucl Med; 1999 Jun 18; 26(6):625-32. PubMed ID: 10369948
    [Abstract] [Full Text] [Related]

  • 13. Is bone scintigraphy necessary in initial staging of prostate cancer patients?
    Jaukovic L, Adjinovic B, Cerovic S, Joksimovic M, Soldatovic Z.
    Hell J Nucl Med; 2011 Jun 18; 14(2):126-30. PubMed ID: 21761013
    [Abstract] [Full Text] [Related]

  • 14. Predicting bone scan findings using sPSA in patients newly diagnosed of prostate cancer: feasibility in Asian population.
    Lai MH, Luk WH, Chan JC.
    Urol Oncol; 2011 Jun 18; 29(3):275-9. PubMed ID: 19734069
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The use of prostate-specific antigen in staging patients with newly diagnosed prostate cancer.
    Oesterling JE, Martin SK, Bergstralh EJ, Lowe FC.
    JAMA; 1993 Jan 06; 269(1):57-60. PubMed ID: 7677962
    [Abstract] [Full Text] [Related]

  • 19. The clinical value of prostate-specific antigen and bone scintigraphy in the staging of patients with newly diagnosed, pathologically proven prostate cancer.
    Rudoni M, Antonini G, Favro M, Baroli A, Brambilla M, Cardani G, Ciardi L, Sacchetti GM, Inglese E.
    Eur J Nucl Med; 1995 Mar 06; 22(3):207-11. PubMed ID: 7540551
    [Abstract] [Full Text] [Related]

  • 20. [Bone scintigraphy findings in patients with recently diagnosed adenocarcinoma of the prostate: relationship with prostate specific antigen levels].
    Ortega A, Alonso JC, Suárez M, Domínguez P, Almoguera I, Bittini A, Gómez A, Martínez L, Herranz F, Pérez-Vázquez JM.
    Rev Esp Med Nucl; 2000 Oct 06; 19(6):409-15. PubMed ID: 11060270
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.